Reta 60mg

Reta 60mg next-generation multi-receptor peptide agonist studied for its activity across GLP-1, GIP, and glucagon receptor pathways. Preclinical and clinical research has explored Reta for its effects on metabolic regulation, energy expenditure, body composition, glucose metabolism, and weight-management mechanisms. Researchers continue to investigate its unique multi-pathway signaling profile and potential applications within metabolic and endocrine research models. Sold for research and educational purposes only.